Ticker archive · $INSM

$INSM Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $INSM — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$INSM

$INSM – Insmed Reports Q3 2026 Revenue of $524.4M, Raises Full-Year BRINSUPRI Guidance

INSMED Inc

2026-10-29 00:00:00 UTC · SEC_8K · All $INSM

?? Positive AI Sentiment (+7.0 / 10)

Total Q3 revenue surged to $524.4M vs $142M YoY, led by BRINSUPRI revenue of $400.1M (up 29% QoQ).
Net loss narrowed substantially to $(100M) or $(0.46) per share compared to $(1.75) per share in Q3 2025.
Company raised full-year 2026 BRINSUPRI guidance, reflecting strong commercial adoption.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?